Clinical Trials
4
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Polarization Perception in Health and Disease. Testing a New Sight Test
- Conditions
- Age Related Macular DegenerationMacular DiseaseCataractPseudophakiaDiabetic RetinopathyRetinal Disease
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- South Warwickshire NHS Foundation Trust
- Target Recruit Count
- 300
- Registration Number
- NCT03823092
- Locations
- 🇬🇧
South Warwickshire NHS Foundation Trust, Warwick, Warwickshire, United Kingdom
What After the First Propess
Phase 2
Terminated
- Conditions
- Induction of Labor
- Interventions
- Drug: 3 mg Dinoprostone vaginal tablet; Pfizer, UKDrug: Aquacryl hydrogel rod; HPSRx Enterprises, USADrug: 10 mg Dinoprostone; CTS, UK
- First Posted Date
- 2016-11-06
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- South Warwickshire NHS Foundation Trust
- Target Recruit Count
- 85
- Registration Number
- NCT02956785
- Locations
- 🇬🇧
Walsall Healthcare NHS Trust, Walsall, United Kingdom
Warwick Metal On Metal Study
Completed
- Conditions
- Metal Hip Replacement
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- South Warwickshire NHS Foundation Trust
- Target Recruit Count
- 750
- Registration Number
- NCT02262468
News
No news found